BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Romero-Gomez M, Eslam M, Ruiz A, Maraver M. Genes and hepatitis C: susceptibility, fibrosis progression and response to treatment. Liver Int 2011;31:443-60. [PMID: 21382156 DOI: 10.1111/j.1478-3231.2011.02449.x] [Cited by in Crossref: 43] [Cited by in F6Publishing: 43] [Article Influence: 3.6] [Reference Citation Analysis]
Number Citing Articles
1 Ateya RM, Afifi SA, Abd Al Monem N, Al-karamany AS, Bessar AA, Rageh F, Ahmed SS, Ghareeb D. Impact of IL-28B gene polymorphism on chronic hepatitis-C patients progression with diabetes and non-diabetes. Egypt J Med Hum Genet 2022;23. [DOI: 10.1186/s43042-022-00239-3] [Reference Citation Analysis]
2 Manns MP, Maasoumy B. Breakthroughs in hepatitis C research: from discovery to cure. Nat Rev Gastroenterol Hepatol 2022;19:533-50. [PMID: 35595834 DOI: 10.1038/s41575-022-00608-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
3 Zhou S, Liu M, Xia Y, Zhang L, Shao L, Wang N, Yu W, Ding N, Zhang K, Liang X. Association of the 3' untranslated region polymorphisms of HLA-G with susceptibility to chronic hepatitis C virus infection in the Chinese population. Hum Immunol 2021:S0198-8859(21)00213-5. [PMID: 34556350 DOI: 10.1016/j.humimm.2021.09.001] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
4 Rauff B, Amar A, Chudhary SA, Mahmood S, Tayyab GUN, Hanif R. Interferon-λ rs12979860 genotype association with liver fibrosis in chronic hepatitis C (CHC) patients in the Pakistani population. Arch Virol 2021;166:1047-56. [PMID: 33528661 DOI: 10.1007/s00705-020-04901-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Zhou S, Liang X, Wang N, Shao L, Yu W, Ding N, Zhang K, Liu M. Association of human platelet antigens polymorphisms with the levels of serum fibrosis marks in chronic hepatitis C patients. Transfus Apher Sci 2021;60:102967. [PMID: 33059995 DOI: 10.1016/j.transci.2020.102967] [Reference Citation Analysis]
6 Jalil I, Arshad M, Khan S, Dasti JI. The STAT4 and not the IFNL3 variant is associated with hepatitis B virus clearance in a population from the Khyber Pakhtunkhwa region of Pakistan. Arab J Gastroenterol 2020;21:91-4. [PMID: 32439233 DOI: 10.1016/j.ajg.2020.04.011] [Reference Citation Analysis]
7 Shaala AY, Morsi MG, Harfoush RAH, Elkhouly EH, Ahmed MAR, Roshdy MN. Role of IL-28B polymorphisms in virologic response to combined pegylated interferon and ribavirin therapy in genotype 4 chronic HCV infected patients with and without cirrhosis. Alexandria Journal of Medicine 2015;51:231-9. [DOI: 10.1016/j.ajme.2014.09.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
8 Connolly JC, Lim JK. Non-invasive Fibrosis Assessment of Patients with Hepatitis C: Application of Society Guidelines to Clinical Practice. Curr Hepatology Rep 2019;18:249-58. [DOI: 10.1007/s11901-019-00471-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
9 Sharkawy RE, Bayoumi A, Metwally M, Mangia A, Berg T, Romero-Gomez M, Abate ML, Irving WL, Sheridan D, Dore GJ, Spengler U, Lampertico P, Bugianesi E, Weltman M, Mollison L, Cheng W, Riordan S, Santoro R, Gallego-Durán R, Fischer J, Nattermann J, D'Ambrosio R, McLeod D, Powell E, Latchoumanin O, Thabet K, Najim MAM, Douglas MW, Liddle C, Qiao L, George J, Eslam M; International Liver Disease Genetics Consortium (ILDGC). A variant in the MICA gene is associated with liver fibrosis progression in chronic hepatitis C through TGF-β1 dependent mechanisms. Sci Rep 2019;9:1439. [PMID: 30723271 DOI: 10.1038/s41598-018-35736-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
10 Xie Z, Li Y, Long L, Liang H, Cai W, Shen T. Polymorphisms in the Th17 cell-related RORC gene are associated with spontaneous clearance of HCV in Chinese women. BMC Infect Dis 2018;18:254. [PMID: 29866105 DOI: 10.1186/s12879-018-3153-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
11 Husain H, Ahmad R, Khan A, Inamuddin, Asiri AM. Proteomic-genomic adjustments and their confluence for elucidation of pathways and networks during liver fibrosis. International Journal of Biological Macromolecules 2018;111:379-92. [DOI: 10.1016/j.ijbiomac.2017.12.168] [Cited by in Crossref: 8] [Cited by in F6Publishing: 10] [Article Influence: 1.6] [Reference Citation Analysis]
12 Barkhash AV, Kochneva GV, Chub EV, Romaschenko AG. Single nucleotide polymorphism rs1800872 in the promoter region of the IL10 gene is associated with predisposition to chronic hepatitis C in Russian population. Microbes Infect 2018;20:212-6. [PMID: 29247709 DOI: 10.1016/j.micinf.2017.11.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
13 Zhou SH, Liang XH, Shao LN, Yu WJ, Zhao C, Liu M. Association of human platelet antigens polymorphisms with susceptibility to hepatitis C virus infection in Chinese population. Int J Immunogenet 2017;44:337-42. [PMID: 28929626 DOI: 10.1111/iji.12341] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
14 Moqueet N, Kanagaratham C, Gill MJ, Hull M, Walmsley S, Radzioch D, Saeed S, Platt RW, Klein MB; Canadian Co-infection Cohort Study (CTN 222). A prognostic model for development of significant liver fibrosis in HIV-hepatitis C co-infection. PLoS One 2017;12:e0176282. [PMID: 28467457 DOI: 10.1371/journal.pone.0176282] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
15 Ali M, Afzal S, Zia A, Hassan A, Khalil AT, Ovais M, Shinwari ZK, Idrees M. A systematic review of treatment response rates in Pakistani hepatitis C virus patients; current prospects and future challenges. Medicine (Baltimore) 2016;95:e5327. [PMID: 27977575 DOI: 10.1097/MD.0000000000005327] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
16 Taratina OV, Samokhodskaya LM, Krasnova TN, Mukhin NA. Association of gene polymorphisms of the reninangiotensin system and endothelial dysfunction with development and severity of portal hypertension in patients with chronic hepatitis C. Alʹm klin med 2016;44:698-712. [DOI: 10.18786/2072-0505-2016-44-6-698-712] [Reference Citation Analysis]
17 Severson TJ, Besur S, Bonkovsky HL. Genetic factors that affect nonalcoholic fatty liver disease: A systematic clinical review. World J Gastroenterol 2016; 22(29): 6742-6756 [PMID: 27547017 DOI: 10.3748/wjg.v22.i29.6742] [Cited by in CrossRef: 60] [Cited by in F6Publishing: 62] [Article Influence: 8.6] [Reference Citation Analysis]
18 Barkhash AV, Babenko VN, Voevoda MI, Romaschenko AG. Association of IL28B and IL10 gene polymorphism with predisposition to tick-borne encephalitis in a Russian population. Ticks and Tick-borne Diseases 2016;7:808-12. [DOI: 10.1016/j.ttbdis.2016.03.019] [Cited by in Crossref: 25] [Cited by in F6Publishing: 25] [Article Influence: 3.6] [Reference Citation Analysis]
19 Grandi T, Silva CM, Amaral KM, Picon PD, Costi C, Fré NN, Fiegenbaum M, Gregianini TS, Niel C, Rossetti ML. Tumour necrosis factor -308 and -238 promoter polymorphisms are predictors of a null virological response in the treatment of Brazilian hepatitis C patients. Mem Inst Oswaldo Cruz 2014;109:345-51. [PMID: 24789557 DOI: 10.1590/0074-0276130372] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
20 Moreira ST, Silva GF, de Moraes CF, Grotto RM, de Moura Campos Pardini MI, Bicalho Mda G, Moliterno RA. Influence of cytokine and cytokine receptor gene polymorphisms on the degree of liver damage in patients with chronic hepatitis C. Meta Gene 2016;9:90-6. [PMID: 27200267 DOI: 10.1016/j.mgene.2016.04.003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
21 Moqueet N, Cooper C, Gill J, Hull M, Platt RW, Klein MB; Canadian Co-infection Cohort. Responder Interferon λ Genotypes Are Associated With Higher Risk of Liver Fibrosis in HIV-Hepatitis C Virus Coinfection. J Infect Dis 2016;214:80-6. [PMID: 26984148 DOI: 10.1093/infdis/jiw088] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.1] [Reference Citation Analysis]
22 Rady NH, Darwish RK, Mogahed EA, Mandour IA, Abo Youssef H, Sharaf SAA, El-karaksy HM. Potential genetic markers for prediction of treatment response in Egyptian children infected with HCV genotype 4. Cytokine 2015;75:349-55. [DOI: 10.1016/j.cyto.2015.04.005] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
23 Moqueet N, Infante-Rivard C, Platt RW, Young J, Cooper C, Hull M, Walmsley S, Klein MB; Canadian Co-Infection Study Investigators. Favourable IFNL3 genotypes are associated with spontaneous clearance and are differentially distributed in Aboriginals in Canadian HIV-hepatitis C co-infected individuals. Int J Mol Sci 2015;16:6496-512. [PMID: 25803108 DOI: 10.3390/ijms16036496] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.5] [Reference Citation Analysis]
24 Eslam M, Hashem AM, Leung R, Romero-Gomez M, Berg T, Dore GJ, Chan HL, Irving WL, Sheridan D, Abate ML. Interferon-λ rs12979860 genotype and liver fibrosis in viral and non-viral chronic liver disease. Nat Commun. 2015;6:6422. [PMID: 25740255 DOI: 10.1038/ncomms7422] [Cited by in Crossref: 137] [Cited by in F6Publishing: 142] [Article Influence: 17.1] [Reference Citation Analysis]
25 Hoffmann FS, Schmidt A, Dittmann Chevillotte M, Wisskirchen C, Hellmuth J, Willms S, Gilmore RH, Glas J, Folwaczny M, Müller T, Berg T, Spengler U, Fitzmaurice K, Kelleher D, Reisch N, Rice CM, Endres S, Rothenfusser S. Polymorphisms in melanoma differentiation-associated gene 5 link protein function to clearance of hepatitis C virus. Hepatology 2015;61:460-70. [PMID: 25130193 DOI: 10.1002/hep.27344] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 3.5] [Reference Citation Analysis]
26 Belbasis L, Panagiotou OA, Dosis V, Evangelou E. A systematic appraisal of field synopses in genetic epidemiology: a HuGE review. Am J Epidemiol 2015;181:1-16. [PMID: 25504025 DOI: 10.1093/aje/kwu249] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.3] [Reference Citation Analysis]
27 Rebbani K, Ezzikouri S, Marchio A, Ababou M, Kitab B, Dejean A, Kandil M, Pineau P, Benjelloun S. Common polymorphic effectors of immunity against hepatitis B and C modulate susceptibility to infection and spontaneous clearance in a Moroccan population. Infection, Genetics and Evolution 2014;26:1-7. [DOI: 10.1016/j.meegid.2014.04.019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
28 Barkhash AV, Kochneva GV, Chub EV, Mikhailova SV, Romaschenko AG. Association between polymorphisms in OAS2 and CD209 genes and predisposition to chronic hepatitis C in Russian population. Microbes Infect 2014;16:445-9. [PMID: 24594345 DOI: 10.1016/j.micinf.2014.02.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
29 Youssef SS, Abbas EAE, Mostafa A, el Zanaty T, Seif SM. Association of IL28B Polymorphism with Fibrosis, Liver Inflammation, Gender Respective Natural History of Hepatitis C Virus in Egyptian Patients with Genotype 4. Journal of Interferon & Cytokine Research 2014;34:22-7. [DOI: 10.1089/jir.2013.0036] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
30 Villar LM, Del Campo JA, Ranchal I, Lampe E, Romero-Gomez M. Association between vitamin D and hepatitis C virus infection: A meta-analysis. World J Gastroenterol 2013; 19(35): 5917-5924 [PMID: 24124339 DOI: 10.3748/wjg.v19.i35.5917] [Cited by in CrossRef: 65] [Cited by in F6Publishing: 67] [Article Influence: 6.5] [Reference Citation Analysis]
31 Tripathi LP, Mizuguchi K. A combined proteomics and computational approach provides a better understanding of HCV-induced liver disease. Expert Rev Proteomics. 2012;9:493-496. [PMID: 23194266 DOI: 10.1586/epr.12.47] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
32 Rodríguez-Torres M. Challenges in the treatment of chronic hepatitis C in the HIV/HCV-coinfected patient. Expert Rev Anti Infect Ther 2012;10:1117-28. [PMID: 23199398 DOI: 10.1586/eri.12.107] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
33 Jiménez-Sousa MA, Fernández-Rodríguez A, Guzmán-Fulgencio M, García-Álvarez M, Resino S. Meta-analysis: implications of interleukin-28B polymorphisms in spontaneous and treatment-related clearance for patients with hepatitis C. BMC Med. 2013;11:6. [PMID: 23298311 DOI: 10.1186/1741-7015-11-6] [Cited by in Crossref: 64] [Cited by in F6Publishing: 74] [Article Influence: 6.4] [Reference Citation Analysis]
34 Derbala M, Rizk N, Shebl F, Alkaabi S, Eldweik N, John A, Sharma M, Yaqoob R, Almohanadi M, Butt M, Alejji K. Interleukin-28 and hepatitis C virus genotype-4: Treatment-induced clearance and liver fibrosis. World J Gastroenterol 2012; 18(47): 7003-7008 [PMID: 23323000 DOI: 10.3748/wjg.v18.i47.7003] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 15] [Article Influence: 1.3] [Reference Citation Analysis]
35 Cieśla A, Bociąga-Jasik M, Sobczyk-Krupiarz I, Głowacki MK, Owczarek D, Cibor D, Sanak M, Mach T. IL28B polymorphism as a predictor of antiviral response in chronic hepatitis C. World J Gastroenterol 2012; 18(35): 4892-4897 [PMID: 23002361 DOI: 10.3748/wjg.v18.i35.4892] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 17] [Article Influence: 1.3] [Reference Citation Analysis]
36 Shi KQ, Liu WY, Lin XF, Fan YC, Chen YP, Zheng MH. Interleukin-28B polymorphisms on the SVR in the treatment of naïve chronic hepatitis C with pegylated interferon-α plus ribavirin: a meta-analysis. Gene 2012;507:27-35. [PMID: 22842190 DOI: 10.1016/j.gene.2012.07.026] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
37 Singaravelu R, Nasheri N, Sherratt A, Pezacki JP. Systems biology methods help develop a better understanding of hepatitis C virus-induced liver injury. Hepatology 2012;56:1-4. [PMID: 22430896 DOI: 10.1002/hep.25727] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.3] [Reference Citation Analysis]
38 Rasmussen AL, Tchitchek N, Susnow NJ, Krasnoselsky AL, Diamond DL, Yeh MM, Proll SC, Korth MJ, Walters KA, Lederer S, Larson AM, Carithers RL, Benecke A, Katze MG. Early transcriptional programming links progression to hepatitis C virus-induced severe liver disease in transplant patients. Hepatology 2012;56:17-27. [PMID: 22278598 DOI: 10.1002/hep.25612] [Cited by in Crossref: 19] [Cited by in F6Publishing: 17] [Article Influence: 1.7] [Reference Citation Analysis]
39 Hayes CN, Imamura M, Aikata H, Chayama K. Genetics of IL28B and HCV--response to infection and treatment. Nat Rev Gastroenterol Hepatol 2012;9:406-17. [PMID: 22641049 DOI: 10.1038/nrgastro.2012.101] [Cited by in Crossref: 77] [Cited by in F6Publishing: 83] [Article Influence: 7.0] [Reference Citation Analysis]
40 Khattab MA, Eslam M. The impact of host factors on management of hepatitis C virus. Hepat Mon 2012;12:235-41. [PMID: 22690229 DOI: 10.5812/hepatmon.709] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
41 Sarin SK, Kumar M. Natural history of HCV infection. Hepatol Int 2012;6:684-95. [DOI: 10.1007/s12072-012-9355-6] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 1.5] [Reference Citation Analysis]
42 Di Marco V, Bronte F, Calvaruso V, Capra M, Borsellino Z, Maggio A, Renda MC, Pitrolo L, Lo Pinto MC, Rizzo M, Fiorenza F, Gerardi C, Grimaudo S, Di Cristina A, Levrero M, Craxì A. IL28B polymorphisms influence stage of fibrosis and spontaneous or interferon-induced viral clearance in thalassemia patients with hepatitis C virus infection. Haematologica 2012;97:679-86. [PMID: 22180419 DOI: 10.3324/haematol.2011.050351] [Cited by in Crossref: 36] [Cited by in F6Publishing: 39] [Article Influence: 3.0] [Reference Citation Analysis]
43 Lau-Corona D, Kershenobich D, Gutierrez-Reyes G. The impact of genetic variability on liver disease in the Hispanic/Latin-American population. Autoimmunity 2011;44:549-54. [PMID: 21864063 DOI: 10.3109/08916934.2011.592883] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
44 Puri CP. Interleukin 28B Polymorphisms and Hepatitis C-Translating the Association into Clinical Decision Making. J Clin Exp Hepatol 2011;1:27-33. [PMID: 25755307 DOI: 10.1016/S0973-6883(11)60115-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]